Insulin therapy, vital for diabetes management, is often misunderstood. It's not a sign of failure or addiction, nor does it ...

Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Injection Pen Training Video Featuring Unifine SafeControl Safety Pen Needle ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

The video shows the family caregiver drawing up insulin into a syringe and then injecting the insulin into the family member’s abdomen. In this video, set in a hospital Emergency Department, a nurse ...

This innovative product is poised to enhance diabetes care across India by reducing the dependency on injectable insulin, catering to those uncomfortable with needles and promoting effective blood ...

A healthy lifestyle, timely medication, and regular blood sugar monitoring are key components of diabetes management ...

"By reducing the need for multiple daily insulin injections, we are offering a convenient solution for people living with diabetes mellitus, particularly those who are uncomfortable with needles, ...

Mumbai: Cipla Limited has announced that it has obtained regulatory approval from Central Drugs Standard Control Organisation ...

NN-1845 is a recombinant protein commercialized by Novo Nordisk, with a leading Phase I program in Type 1 Diabetes (Juvenile Diabetes).